View in EDS HTML Full Text PDF Full Text

Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy.

Saved in:
Bibliographic Details
Title: Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy.
Authors: Itzler R; CSL Behring, King of Prussia, Pennsylvania, USA., Buckner TW; Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA., Leebeek FWG; Department of Hematology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Miller J; Everest Clinical Research, New Jersey, USA., Recht M; National Bleeding Disorders Foundation, New York, New York, USA.; Yale University School of Medicine, New Haven, Connecticut, USA., Drelich D; CSL Behring, King of Prussia, Pennsylvania, USA., Monahan PE; CSL Behring, King of Prussia, Pennsylvania, USA., Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 May; Vol. 30 (3), pp. 709-719. Date of Electronic Publication: 2024 Mar 10.
Publication Type: Journal Article; Clinical Trial, Phase III
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38462823
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Itzler+R%22">Itzler R</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Buckner+TW%22">Buckner TW</searchLink>; Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Leebeek+FWG%22">Leebeek FWG</searchLink>; Department of Hematology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Miller+J%22">Miller J</searchLink>; Everest Clinical Research, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Recht+M%22">Recht M</searchLink>; National Bleeding Disorders Foundation, New York, New York, USA.; Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Drelich+D%22">Drelich D</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Monahan+PE%22">Monahan PE</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Pipe+SW%22">Pipe SW</searchLink>; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229442916%22">Haemophilia : the official journal of the World Federation of Hemophilia</searchLink> [Haemophilia] 2024 May; Vol. 30 (3), pp. 709-719. <i>Date of Electronic Publication: </i>2024 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9442916 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2516 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213518216%22">13518216 </searchLink><i>NLM ISO Abbreviation: </i>Haemophilia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38462823
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/hae.14977
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 709
    Titles:
      – TitleFull: Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Itzler R
      – PersonEntity:
          Name:
            NameFull: Buckner TW
      – PersonEntity:
          Name:
            NameFull: Leebeek FWG
      – PersonEntity:
          Name:
            NameFull: Miller J
      – PersonEntity:
          Name:
            NameFull: Recht M
      – PersonEntity:
          Name:
            NameFull: Drelich D
      – PersonEntity:
          Name:
            NameFull: Monahan PE
      – PersonEntity:
          Name:
            NameFull: Pipe SW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2516
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Haemophilia : the official journal of the World Federation of Hemophilia
              Type: main
ResultId 1